Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -1.11M | -1.41M | -1.83M | -1.78M |
| Total Depreciation and Amortization | 177.70K | 175.70K | 180.50K | 181.40K | 183.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -108.70K | -152.10K | -122.40K | 6.00K | 5.50K |
| Change in Net Operating Assets | 167.40K | -562.90K | 419.10K | 247.10K | 248.80K |
| Cash from Operations | -842.80K | -1.65M | -934.30K | -1.40M | -1.34M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 12.70K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 79.90K | 116.40K | 118.50K | 118.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 11.10K | 0.00 |
| Cash from Investing | 0.00 | 79.90K | 116.40K | 142.30K | 118.50K |
| Total Debt Issued | 849.50K | 1.51M | 1.06M | 1.10M | 1.03M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 76.80K | 102.20K | 276.60K | 374.60K |
| Cash from Financing | 849.50K | 1.58M | 1.16M | 1.38M | 1.41M |
| Foreign Exchange rate Adjustments | -5.60K | -13.50K | -347.00K | -167.10K | -187.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00K | 2.90K | -2.30K | -47.20K | 700.00 |